FibroGen (FGEN) Tops Q3 EPS by 3c

FibroGen (NASDAQ: FGEN) reported Q3 EPS of ($0.65), $0.03 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $40.1 million versus the consensus estimate of $36.84 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• Morgan Stanley upgrades CDW on stronger AI-driven server demand